The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 13, 2023

Filed:

Dec. 18, 2020
Applicants:

The Hospital for Sick Children, Toronto, CA;

The Royal Institution for the Advancement of Learning/mcgill University, Montreal, CA;

Inventors:

Lynne P. Howell, Toronto, CA;

Perrin Baker, Mississauga, CA;

Noor Alnabelseya, San Francisco, CA (US);

Natalie Bamford, Toronto, CA;

Dustin Little, Burlington, CA;

Donald Sheppard, Montreal, CA;

Brendan Snarr, North Bethesda, MD (US);

Mark Jae Lee, Burbank, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12N 9/24 (2006.01); A61K 38/47 (2006.01); A61L 29/16 (2006.01); A61L 27/54 (2006.01); A61K 45/06 (2006.01); A01N 63/50 (2020.01); A01N 63/30 (2020.01); A01N 63/10 (2020.01); A01N 63/00 (2020.01); A61K 35/74 (2015.01); A61L 27/34 (2006.01); A61L 29/08 (2006.01); A61L 31/10 (2006.01); A61L 31/16 (2006.01);
U.S. Cl.
CPC ...
A61K 38/47 (2013.01); A01N 63/00 (2013.01); A01N 63/10 (2020.01); A01N 63/30 (2020.01); A01N 63/50 (2020.01); A61K 35/74 (2013.01); A61K 45/06 (2013.01); A61L 27/34 (2013.01); A61L 27/54 (2013.01); A61L 29/085 (2013.01); A61L 29/16 (2013.01); A61L 31/10 (2013.01); A61L 31/16 (2013.01); C12N 9/2402 (2013.01); C12Y 302/01 (2013.01); A61L 2300/252 (2013.01); A61L 2300/254 (2013.01); A61L 2300/404 (2013.01); A61L 2420/00 (2013.01); A61L 2430/24 (2013.01); Y02A 50/30 (2018.01);
Abstract

The present disclosure relates to methods of treating or preventing a biofilm-related infection and methods of preventing and treating biofilm formation on indwelling medical devices, implants, and non-medical surfaces comprising administering at least one soluble microbial protein that is encoded by an exopolysaccharide biosynthetic operon or functional gene cluster, wherein the protein comprises a glycosyl hydrolase domain. The present disclosure further provides particular soluble glycosyl hydrolases and compositions thereof.


Find Patent Forward Citations

Loading…